Alnylam Pharmaceuticals | ALNY

Aktienkurs
236.22
Täglich Wechseln
6.92 3.02%
Monatlich
-11.52%
Jährlich
-48.01%
Q3 Prognose
223.73

EPS Referenz Zeit Aktuell Konsens Zuletzt
2026-10-29 FY2026Q3 AM 1.97 2.90
2026-07-30 FY2026Q2 AM 1.84 1.61 0.32
2026-04-30 FY2026Q1 AM 1.99 0.99 -0.01
2026-02-12 FY2025Q4 AM 1.25 1.27 0.06
2025-10-30 FY2025Q3 AM 2.90 0.27 -0.50



Preis Chg Tag Jahr Datum
Takeda 5,764.00 -61.00 -1.05% 25.60% 2026-08-21
Acadia Pharmaceuticals 29.51 0.47 1.62% 14.65% 2026-08-21
Agios Pharmaceuticals 33.09 -0.54 -1.61% -14.72% 2026-08-21
Alnylam Pharmaceuticals 236.22 6.92 3.02% -48.01% 2026-08-21
Amgen 439.33 5.60 1.29% 49.57% 2026-08-21
Arrowhead Research 86.09 -1.38 -1.58% 303.61% 2026-08-21
Tectonic Therapeutic 37.27 1.22 3.37% 42.34% 2026-08-21
BioCryst Pharmaceuticals 9.65 -0.01 -0.10% 12.73% 2026-08-21
BioMarin Pharmaceutical 66.70 -0.98 -1.45% 13.86% 2026-08-21
Incyte 129.15 1.93 1.52% 51.87% 2026-08-21

Preis Tag Jahr Datum
USND 26180 113.29 0.43% 21.79% 2026-08-21